CMR Surgical Stock / Medical DevicesFounded: 2014

With the aim to make the benefits of minimal access surgery available to everyone who needs it, CMR Surgical, is a British medical device company based in Cambridge, producing a robotic surgery system called Versius, incorporated in 2014. CMR is committed to working with surgeons, surgical teams and hospital partners, to provide an optimal tool to make robotic minimal access surgery universally accessible and affordable.

Register To Buy and Sell Shares

For more details on financing and valuation for CMR Surgical, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access CMR Surgical’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like CMR Surgical.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.

CMR Surgical investors also invested in these private companies


Management Team

Per Vegard Nerseth
Chief Executive Officer
Anna Wasyl
Chief Financial Officer
Barrington D'Arcy
Chief Operations Officer
Luke Hares
Chief Technology Officer & Co-Founder
Bertrand Weil
Chief Business Development Officer
Ian Cardwell
Chief People Officer
Paul Roberts Ph.D
Chief Customer Success Officer & Co-Founder
Steve Bell
Chief Commercial Officer
Chris Weatherall
Chief Quality and Regulatory Officer
Mark Slack MD
Co-Founder & Chief Medical Officer

Board Members

Elizabeth Wells
SoftBank Investment Advisers

Frequently Asked Questions About CMR Surgical’s Stock

Can you buy CMR Surgical’s stock?
CMR Surgical is not publicly traded on NYSE or NASDAQ in the U.S. To buy CMR Surgical’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell CMR Surgical’s stock?
Yes, you can sell stock of a private company like CMR Surgical. Forge can help you sell your CMR Surgical stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is CMR Surgical’s stock price?
CMR Surgical is a privately held company and therefore does not have a public stock price. However, you may access CMR Surgical’s private market stock price with Forge Data.
What is CMR Surgical’s stock ticker symbol?
CMR Surgical does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

CMR Surgical reports record surgical robot installations to end 2023, plans 2024 product launches
"CMR Surgical has reported a record number of installations of its Versius surgical robot in Q4 2023. The company also plans to offer advanced technologies to support the use of Versius in 2024, including enhancements in vision, instrumentation, and digital. The company's Versius global install base was more than 50% higher than in 2022, with over 17,000 surgical procedures completed using Versius, marking a growth of over 60%.
Hospital in Germany adopts Versius surgical robot from CMR Surgical
Kreiskrankenhaus Rotenburg, a German hospital, has adopted the Versius surgical robot from CMR Surgical. This marks the hospital's first introduction of robotic surgery. The hospital plans to use Versius for a range of surgeries, including complex visceral surgery and abdominal tumour surgery. This latest installation brings the global total of Versius robots to over 140. CMR Surgical raised $165m in September to support Versius.
Signal: CMR Surgical Raises $165m to continue development of surgical robot
"CMR Surgical has raised $165m in funding to continue developing its Versius surgical robot. This brings the UK-based company's total funding to over $1bn, confirming its status as a unicorn. CMR, founded in 2014, is a major competitor of US surgical robotics market leader Intuitive Surgical. The Versius robot has completed 15,000 surgeries and is used in over 20 countries. The company's growth potential is significant if it can continue to take market share from Intuitive Surgical, currently valued at over $100bn.
Updated on: Jun 18, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.